Disc Medicine Inc (IRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -109,357 | -79,900 | -53,301 | -26,949 | -76,429 |
| Depreciation Amortization | -5,148 | -2,945 | -460 | 26 | 100 |
| Accounts payable and accrued liabilities | -4,681 | -9,076 | -8,029 | -7,360 | -3,741 |
| Other Working Capital | 3,231 | 3,729 | -3,674 | -10,876 | -2,953 |
| Other Operating Activity | 22,029 | 21,839 | 16,472 | 11,560 | 9,561 |
| Operating Cash Flow | $-93,926 | $-66,353 | $-48,992 | $-33,599 | $-73,462 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -505 | -56 | -64 | -67 | -89 |
| Purchase Of Investment | -386,627 | -313,850 | -219,752 | N/A | N/A |
| Sale Of Investment | 94,800 | 23,000 | N/A | N/A | N/A |
| Investing Cash Flow | $-292,332 | $-290,906 | $-219,816 | $-67 | $-89 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 28,988 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 190,719 | 189,076 | 188,846 | 15,655 | 239,379 |
| Other Financing Activity | -1,393 | 441 | 245 | 245 | 0 |
| Financing Cash Flow | $218,314 | $189,517 | $189,091 | $15,900 | $239,379 |
| Beginning Cash Position | 360,616 | 360,616 | 360,616 | 360,616 | 194,788 |
| End Cash Position | 192,672 | 192,874 | 280,899 | 342,850 | 360,616 |
| Net Cash Flow | $-167,944 | $-167,742 | $-79,717 | $-17,766 | $165,828 |
| Free Cash Flow | |||||
| Operating Cash Flow | -93,926 | -66,353 | -48,992 | -33,599 | -73,462 |
| Capital Expenditure | -505 | -56 | -64 | -67 | -89 |
| Free Cash Flow | -94,431 | -66,409 | -49,056 | -33,666 | -73,551 |